IOM releases summary of workshop on drug-resistant TB in India

NewsGuard 100/100 Score
Apr 27 2012

The Institute of Medicine (IOM) on Friday released a summary of a joint workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research, titled, "Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India." According to the report's webpage, "The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of [tuberculosis (TB)] in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB" (4/27).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Medical Research News | Disease/Infection News

    Tags: , , , , ,

    Comments (0)

    Suggested Reading

    Feeling lonely? It may affect how your brain reacts to food, new research suggests
    Diet's role in fighting vitiligo highlighted in new research
    Rising antibiotic resistance prompts shift to ecological research strategies in infection control
    Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies
    Study reveals lasting lung damage in tuberculosis survivors
    Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis
    Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses
    The path to a better tuberculosis vaccine runs through Montana

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis